Mochida Pharmaceutical Co's revenue for the
three
months ended in Dec. 2023 was 円28,742 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was 円100,085 Mil.
Mochida Pharmaceutical Co's Revenue per Share for the
three
months ended in Dec. 2023 was 円808.29.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円2,771.58.
Warning Sign:
Mochida Pharmaceutical Co Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Mochida Pharmaceutical Co was -2.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 2.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -8.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 2.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Mochida Pharmaceutical Co's highest 3-Year average Revenue per Share Growth Rate was 35.10% per year. The lowest was -20.90% per year. And the median was 4.70% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mochida Pharmaceutical Co's Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Mochida Pharmaceutical Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mochida Pharmaceutical Co's Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mochida Pharmaceutical Co's Revenue distribution charts can be found below:
* The bar in red indicates where Mochida Pharmaceutical Co's Revenue falls into.
Mochida Pharmaceutical Co Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円100,085 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mochida Pharmaceutical Co (TSE:4534) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Mochida Pharmaceutical Co Revenue Related Terms
Thank you for viewing the detailed overview of Mochida Pharmaceutical Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Mochida Pharmaceutical Co (TSE:4534) Business Description
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4534 has been successfully added to your 